Pathogenic organisms are frequently attenuated after long-term culture in vitro. The mechanisms of the attenuation process are not clear, but probably involve mutations of functions required for replication and pathogenicity in vivo. To identify these functions, a direct comparison must be made between attenuated genomes and those that remain pathogenic in vivo. In this study, we used the heterochimeric SCID-hu Thy/Liv mouse as an in vivo model to define human immunodeficiency virus type 1 (HIV-1) determinants which are uniquely required for replication in vivo. The Lai/IIIB isolate and its associated infectious molecular clones (e.g., HXB2) were found to infect T cell lines but failed to replicate in the SCID-hu Thy/Liv model. When a lab worker was accidentally infected by Lai/IIIB, however, HIV-1 was isolated only from infection of primary PBMC, and not from infection of T cell lines. We hypothesized that the lab worker was exposed to a heterogeneous viral stock which had been attenuated by passage in immortalized T cell lines. Either a rare family member from this stock was selected for in vivo replication or, alternatively, an attenuated genotype dominant in vitro may have reverted to become more infectious in vivo. To address this hypothesis, we have used the SCID-hu Thy/Liv model to study the replication of HXB2 and of HXB2 recombinant viruses with HIV-1 fragments isolated from the infected lab worker. HXB2 showed no or very low levels of replication in the Thy/Liv organ. Replacement of its subgenomic fragment encoding the envelope gene with a corresponding fragment from the lab worker isolate generated a recombinant virus (HXB2/LW) which replicated actively in SCID-hu mice. The NEF mutation in the HXB2 genome is still present in HXB2/LW. Thus, the LW sequences encode HIV-1 determinants which enhance HIV replication in vivo in a NEF-independent mechanism. The specific determinants have been mapped to the V1-V3 regions of the HIV-1 genome. Six unique mutations in the V3 loop region of HXB2/LW have been identified which contribute to the increased replication in vivo. ᭧ 1997 Academic Press 1 To whom correspondence and reprint requests should be ad-''pathogenic'' ones in vitro and in vivo will help to idendressed at the Lineberger
INTRODUCTION
IIIB stock was prepared by infecting the human T leukemia cell line, H9, with infected M2T0/B cell supernatant. HIV-1 can infect diverse cell types in vivo, including Subsequent analyses of HIV-1 genome from Lai/IIIB iso-CD4 / T cells, macrophages, dendritic cells, Langerhans lates showed that multiple changes have accumulated cells, and hematopoietic progenitor cells (Fauci, 1993;  during their expansion in vitro (Shaw et al., 1984) . For Levy, 1993; Weiss, 1993) . HIV-1 isolates example, the HXB2 genome cloned from Lai/IIIB carries used in most studies have been expanded and mainmutations which lead to premature termination of three tained in immortalized human T cell lines. Since the reof the nine ORFs (vpr, vpu, and nef) . Many other subtle verse transcription process is associated with a high mutations may have also accumulated. These mutations intrinsic error rate, it is predictable that the different sedo not usually affect HIV-1 replication in vitro under the lective pressures in vitro may lead to the generation of specific culture conditions. Some of them may actually variants with uncertain relationship to isolates which preenhance their replication in certain cell lines. For indominate in vivo. Indeed, many lab-adapted isolates of stance, infection of T cells in vitro often leads to selection HIV-1 show defects in gene functions such as vpr, vpu, of HIV-1 mutants carrying mutations in the vpr gene beand nef (Shaw et al., 1984) .
cause vpr causes cell cycle arrest in the infected cells A particularly instructive example of such adaptation (Jowett et al., 1995; Rogel et al., 1995) . However, due to in vitro may be found in the passage history of HTLV-IIIB lack of relevant in vivo models, it is not clear which muta-(Lai/IIIB; Chang et al., 1993) . Initially derived from human tions may contribute to HIV replication and pathogenesis patient blood sample and cultured in M2T0/B cells, Lai/ in vivo. Comparison of ''attenuated'' HIV-1 isolates with models have been established as in vivo models for To address this hypothesis, we have used the SCIDhu Thy/Liv model to study the replication of HXB2 and studying HIV-1 replication and pathogenesis. Human peripheral blood leukocyte (PBL) cells or human fetal of HXB2 recombinant viruses with HIV-1 fragments isolated from the infected lab worker (Kong et al., tissues implanted in the C.B17 scid/scid mouse (hu-PBL-SCID or SCID-hu Thy/Liv, respectively) have been 1989). HXB2 showed no or very low levels of replication in the Thy/Liv organ. Replacement of its subgeno-successfully used to study HIV-1 replication and CD4 / T cell killing in vivo mic fragment encoding the envelope ORF with a corresponding fragment from the LW87-1 isolate generated al., 1989). Important, some unexpected, findings have been documented from these studies. For example, a recombinant virus (HXB2/LW) which replicated actively in SCID-hu mice or in the thymus organ culture it has been shown in the hu-PBL-SCID model that a macrophage-tropic HIV-1 isolate, which is noncyto-(TOC) model (Bonyhadi et al., 1995) . The specific determinants have been mapped to the V1 -V3 regions pathic in vitro, is more potent in killing the CD4 / T cells engrafted in the SCID mouse than the T-tropic of the HIV-1 genome. Six unique mutations in the V3 loop region have been identified which contribute to (cytopathic in vitro) HIV-1 isolate (Mosier et al., 1993) . However, the human PBLs engrafted in SCID mice are its increased replication in vivo. physiologically abnormal due to severe xenoactivation (hyperactivated and anergic) and lack of human RESULTS lymphoid organs (Huppes et al., 1992; Murphy et al., Lab-adapted HIV-1 isolates acquired ability to 1992; Tary-Lehmann and Saxon, 1992) .
replicate in the SCID-hu Thy/Liv mouse after The SCID-hu Thy/Liv model transplants human fetal passages in vivo liver and thymus fragments into SCID mice . The Thy/Liv organ developed in the The HIV-1 clone HXB2, like its parental isolate Lai/ IIIB, replicates poorly in the Thy/Liv organ (Bonyhadi mouse is tolerized to the host and supports long-term, normal T cell development Nami-et al., 1995;  Fig. 1C ). HIV-1 isolated from the lab worker infected with IIIB/Lai showed altered tropism (Kong kawa et al., 1990) . Studies of HIV-1 infection in this model have shown that HIV-1 viruses isolated from et al., 1989; Weiss et al., 1988) . To characterize the mutations accumulated during in vivo replication, a late-stage AIDS patients replicate efficiently and lead to thymus depletion, whereas HIV-1 viruses isolated recombinant viral genome (HXB2/LW) was generated between the molecular clone HXB2 and a 2.7-kb (SalI -from the same patients before AIDS development replicated poorly and did not cause severe thymus dele-BamHI) HIV-1 genomic fragment (LW87-1; Reitz et al., 1994) obtained by short-term culture of phytohemag-tion (Kaneshima et al., 1994) . As shown in the SIV/ monkey model system, the HIV-1 nef function is also glutinin-activated peripheral blood mononuclear cells (PHA-PBMC) of the infected lab worker (Fig. 1A ). This required for efficient replication and pathogenesis in the SCID-hu Thy/Liv model (Jamieson et al., 1994) .
DNA fragment contains HIV-1 3-half sequences encoding tat, rev, vpu, and the majority of env. Analyses of HIV-1 recombinants bearing mutations in the accessory genes have indicated that the vif and Both HXB2 and HXB2/LW replicated efficiently in PHA-PBMCs when p24 antigen levels and TCID 50 were vpu functions may also be required for this process (Aldrovandi and Zack, 1996) . These HIV-1 recombi-measured ( Fig. 1B ). HXB2 or HXB2/LW viral supernatants were injected intrathymically (about 200 TCID 50 nants, except the vif mutant, appeared to replicate to similar levels in PBMC. Thus, the SCID-hu Thy/Liv units/graft). HIV-1 replication was assessed in the SCID-hu Thy/Liv implant by DNA PCR analysis and mouse is a relevant model to study HIV-1 replication in a human lymphoid organ. p24 antigen ELISA. No significant HXB2 replication was detected until late time postinoculation (8 weeks The Lai/IIIB isolate and its associated infectious molecular clones (e.g., HXB2) were found to infect T p.i.). In contrast, challenge with the recombinant HXB2/LW virus was associated with high levels of viral cell lines such as H9 and to be cytopathic in vitro (Hahn et al., 1984; Popovic et al., 1984) . When a lab replication at early time points (3 -6 weeks postinoculation). Quantitation of proviral DNA confirmed that worker was accidentally infected by Lai/IIIB, however, HIV-1 was isolated only from infection of primary about 10% of human thymocytes were infected by HXB2/LW ( Fig. 1D ), comparable to the infection levels PBMC, but not from infection of T cell lines (Kong et al., 1989; Weiss et al., 1988) . We hypothesized that the of NL4.3 or primary isolates (Su et al., 1995) . Thymocytes from HXB2-inoculated human thymus grafts lab worker was exposed to a heterogeneous viral stock which had been attenuated by passage in im-(HB-a and HB-b; Fig. 1D ) showed no sign of HIV-1 replication. The HIV gag band in lane 2 of HB-a was mortalized T cell lines. Either a rare family member from this stock was selected for in vivo replication or, due to contamination, as reanalysis of the same sample showed no HIV-specific PCR product. The human alternatively, an attenuated genotype dominant in vitro may have reverted to become more infectious in vivo.
b-globin product was included as a qualitative control 
for human cells. Immunohistochemical analysis with
Multiple determinants contribute to the enhanced replication in the Thy/Liv organ anti-HIV-1 anti-serum demonstrated HXB2/LW-infec ted cells with both thymocyte and nonthymocyte mor-To map molecular determinants associated with repliphology (data not shown). Similar results were obcation in vivo, recombinants between HXB2 and different tained after challenge of the TOC model system (Bonyparts of the LW87-1 region in HXB2/LW were prepared hadi et al., 1995): as measured by viral p24 production, ( Fig. 2A) . All of the recombinants showed similar replica-HXB2/LW but not HXB2 showed high levels of replication (Fig. 2B) .
tion capacity in PHA-PBMC except LW-H/B, which The 2.7-kb (SalI to BamHI) LW87-1 sequences in HXB2/LW were dissected to generate the following recombinants in the HXB2 genetic background. HXB2/LW, SalI (5786) to BamHI (8466); LW-S/K, SalI (5786) to KpnI (6348); LW-K/B, KpnI (6348) to BglII (7032); LW-B/N, BglII (7032) to NheI (7257); LW-H/B, HindIII (8132) to BamHI (8466). The asterisks indicate the nonsense mutations in the HXB2 genome. LW-S/K replaces the C-terminus of vpr without affecting the nonsense mutation in the vpr gene. The relative replication capacity in vivo (TOC and SCID-hu mice, B and C) of these recombinants is summarized on the right. ///, replication comparable to primary isolates or NL4.3 (p24 levels §500 pg/10 6 cells, §10% infection as determined by DNA PCR); //, p24 level §100 pg/10 6 cells, §1% infection by PCR assay; /, p24 level §10 pg/10 6 cells, õ1% infection by PCR assay; 0, no detectable p24 production, no infection detected by PCR. (B) Replication of HXB2/LW recombinants in TOC. The TOC model was used to screen the recombinants as an initial test of their replication potentials in human thymus. p24 assays were performed 7-8 days postinfection. The labels are as in Fig. 1C . (C) Replication of HXB2/LW recombinants in SCID-hu Thy/Liv mice. HIV-1-infected SCID-hu mice were terminated and analyzed 4-6 weeks postinfection with the indicated HIV-1 clones. Labels are as described in Fig. 1C. showed a delayed replication kinetics (data not shown).
1 region, LW-B/N (a 225-bp fragment encoding the V3 loop and some flanking env sequences) showed the The TOC model was used to facilitate the screening of these recombinants. As shown before ( Fig. 2B and Bony-highest level of replication, whereas LW-K/B (encoding V1V2C2) and LW-S/K (encoding the first exons of tat and hadi et al., 1995), HXB2 replicated poorly in TOC. HXB2/ LW, on the other hand, replicated efficiently in TOC (Fig.  rev, vpu , and the N-terminal 43 amino acids of env) showed lower, but significant, levels of replication. LW-2B). In SCID-hu Thy/Liv (Figs. 1C and 2C) , HXB2 replicated poorly and HXB2/LW replicated to high levels.
H/B (encoding the second exon of tat, part of the second exon of rev, and the transmembrane portion of gp41) Among those recombinants which subdivided the LW87- failed to show any significant replication. Notably, HXB2/ tural properties within the envelope protein. The K / to E 0 change C-terminal to the V3 loop may also result in LW replicated to higher levels than any of these recombinants, suggesting additive or synergistic contributions altered inter-or intramolecular interactions and thereby be associated with properties of infectivity in vivo. Further from individual, segregated regions. Figure 2A summarizes data from TOC as well as SCID-hu mice. At the analysis of these changes may help to illuminate their relative importance to HXB2/LW replication in vivo. resolution of this experiment, however, most of the determinants for HXB2/LW infectivity in vivo were carried in the V1-V3 region of env, especially in the BglII-NheI (V3 DISCUSSION loop) fragment.
It has been reported that HIV-1 isolates which grow out from a given patient in cell culture are not representa-Identification of amino acid residues in the V3 loop tive of those observed within the same patient in vivo region which contribute to the enhanced replication (Meyerhans et al., 1989) . In the case of other lentiviruses, in the Thy/Liv organ single point mutations have been shown to revert an attenuated to a pathogenic strain in vivo (Kestler et al. , The LW-B/N fragment was sequenced (Fig. 3A) . Comparison of its deduced amino acid sequences with that 1991). The present study documents the first example of unique structural determinants in HIV-1 that appear to of HXB2 (Fig. 3B ) revealed six amino acid changes (underlined), three N-terminal to the V3 loop, two in the be necessary for infectivity in vivo, but not in PBMC or in immortalized T cell lines. Interestingly, the relevant V3 loop, and one immediately C-terminal to the V3 loop. The two changes in the V3 loop have been maintained changes do not affect the nef gene, previously implicated for pathogenicity of SIV in rhesus macaques (Kestler et in all viral isolates derived from the lab worker since 1987, 2 years after the accidental infection (Reitz et al., al., 1991) or of HIV-1 in SCID-hu mice (Jamieson et al., 1994) . The vpu and vpr genes, which have also been 1994), and one, the A to T change, has been demonstrated previously to be responsible for resistance to reported to affect HIV-1 replication in SCID-hu Thy/Liv mice (Aldrovandi and Zack, 1996) , of HXB2/LW and the neutralizing antibodies (Di Marzo Veronese et al., 1993; Reitz et al., 1994) . There is otherwise no consistent corre-recombinants also remain defective. Thus, previously undescribed features of the V3 region of env that are neces-lation between the selection for (or against) these particular amino acid residues among other HIV-1 V3 loop sary for infection of natural target cells are revealed by phenotypic and molecular analyses of HIV-1 isolates in sequences (in relation to transmission or in vitro growth characteristics) that have been entered in the data base the human organ implants of the SCID-hu mouse. It is noteworthy that the V3 region of NL4.3 is almost identical (data not shown). If they are critical for infectivity of HXB2/ LW in vivo, their role may be to affect higher order struc-to that of HXB2 (only one A to V change N-terminal to the V3 loop). It is likely that the LW env determinants Aldrovandi and Zack, 1996; Jamieson et al., 1994; Kaneshima et al., 1994 ; Nami-bind/interact with unique target cells and/or receptors to enhance viral replication in the human thymus via a NEF-kawa et al., 1988; Stanley et al., 1993; Su et al., 1995) . It is notable that HIV-1 such as HXB2 (derived from Lai/ independent mechanism.
Thymocytes are clearly the primary cells infected by IIIB), which had been adapted in immortalized T cells and which did not grow out efficiently within the infected HXB2/LW, both by thymocyte-associated p24 assay and by immunohistochemistry (data not shown). The most lab worker, also did not replicate efficiently in the SCIDhu Thy/Liv implant. Such impaired growth in the SCID-likely mechanism of enhanced replication by HXB2/LW is that HXB2/LW infected certain target cells (thymocytes hu Thy/Liv model has been observed with an attenuated measles virus vaccine strain (Auwaerter et al., 1996) and or macrophages) which sensitized the other thymocytes for supporting HIV-1 replication. Cytokines which en-with tissue culture-adapted isolates of cytomegalovirus (Mocarski et al., 1993) . This small animal model may hance HIV-1 replication have been shown to be upregulated in HIV-1-infected Thy/Liv organs (M. Bonyhadi, L.
thus be useful in the definition and characterization of molecular determinants of other pathogenic organisms Su, J. Auten, and H. Kaneshima, unpublished observations) . Identification of those ''initiator cells'' will be of as well as HIV-1 which, when altered, result in attenuated growth in vivo. importance to understand the enhanced replication by HXB2/LW. Alternatively, the LW env region may simply interact uniquely with the receptors on human thymo-MATERIALS AND METHODS cytes to enhance the infectivity of HXB2/LW in human Construction of recombinant HIV-1 genomes thymocytes. Identification of the target cells infected by HXB2/LW will help to clarify this question.
The HXB2 genomic DNA was digested with SalI and The replication of HXB2 in the Thy/Liv organ at late BamHI to drop out the 2.7-kb fragment and the corretime postinfection (8 weeks p.i.; Fig. 1C ) may suggest sponding fragment from LW87.1 was ligated into the prothat HXB2 can infect target cells in the Thy/Liv organ.
virus DNA to generate the HXB2/LW provirus. The muta-However, it either replicates or transmits very slowly in tions in vpr, vpu, and nef are still present in the genome. the target cells. It is also possible that HXB2 may have Construction of HXB2/LW recombinant genomes was acquired mutations which contribute to enhanced replicarried out by subcloning the indicated fragments in cation at late times. It will be of interest to analyze the HXB2/LW into HXB2 proviral DNA. The 2.7-kb (SalI to HIV genome from late time postinfection for possible BamHI) LW87-1 sequences in HXB2/LW were dissected accumulation of specific mutations (e.g., in nef and/or V3 to generate the following recombinants in the HXB2 geloop regions). netic background. HXB2/LW, SalI (5786) to BamHI (8466); It is of great interest that the same SalI to BamHI LW-S/K, SalI (5786) to KpnI (6348); LW-K/B, KpnI (6348) fragment from HXB2 also shows in vivo defects in the to BglII (7032); LW-B/N, BglII (7032) to NheI (7257); LW-SIV-HIV chimeric (SHIV) genome (Lu et al., 1996; Rei H/B, HindIII (8132) to BamHI (8466). The asterisks (Fig. mann et al., 1996) . In one report, SHIV-HXB2c showed 2A) indicate the nonsense mutations in the HXB2 gegreatly reduced replication in infected monkeys comnome. LW-S/K replaces the C-terminus of vpr without pared with SHIV-89.7 (a primary HIV-1 isolate), although affecting the nonsense mutation in the vpr gene. both chimeric viruses replicated efficiently in simian PBLs in vitro (Reimann et al., 1996) . In the second report,
HIV-1 replication in PBMC and viral supernatant the SHIV-HXB2c virus appeared to be defective in estabproduction lishing infection in monkeys after intravaginal inoculation Equal amounts of proviral DNA (20 mg) were trans- (Lu et al., 1996) . Both reports indicate that lab-adapted fected into PHA-activated PBMC as described (Su et al., HIV-1 isolates may have accumulated mutations in im-1995). PHA-activated PBMC (obtained as buffy coats from portant genes for in vivo replication and transmission.
Stanford Blood Center, CA) were cultured at 10 6 cells/ However, the fragment in the SHIV chimeric viruses enml with IL2 (20 units/ml). Supernatant was collected at codes HIV-1 vpr, vpu, rev, and tat, as well as env. It indicated times and stored for p24 assay. TCID 50 assay is not clear which gene(s) contributes to the observed (10-fold dilution) was performed with PHA-PMBC. The differences.
supernatant with TCID 50 greater than 4000/ml (p24 levels The Thy/Liv organ of the SCID-hu mouse has served 100-200 ng/ml) was stored as viral stock for infection. previously as a useful model for the analysis of normal thymocyte differentiation (Kraft et al., 1993; Krowka et al., Infection of SCID-hu mice or TOC 1991; McCune et al., 1988; Vandekerckhove et al., 1992; Waller et al., 1992) . As judged by the parameters of viral Animal transplantation procedures for SCID-hu Thy/ Liv construction have been described elsewhere (Nami-replication, tropism, cytopathic effects, and in vivo antiviral effects, it also appears to faithfully reproduce the kawa et al., 1990). Infection of SCID-Thy/Liv mice was performed as described (Su et al., 1995) . Briefly, SCID-expected attributes of HIV-1 infection in vivo (Aldrovandi
